Lykke Pedersen

Person

Horsholm, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Oligonucleotides for inducing paternal UBE3A expression
- Patent number 12,259,380
- Issue date Mar 25, 2025
- HOFFMANN-LA ROCHE INC.
- Veronica Costa
- G01 - MEASURING TESTING
Information Patent Grant
Oligonucleotides for modulating SCN9A expression
- Patent number 12,116,576
- Issue date Oct 15, 2024
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhanced oligonucleotides for inhibiting RTEL1 expression
- Patent number 11,898,145
- Issue date Feb 13, 2024
- HOFFMANN-LA ROCHE INC.
- Erik Funder
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for inducing paternal UBE3A expression
- Patent number 11,852,627
- Issue date Dec 26, 2023
- HOFFMANN-LA ROCHE INC.
- Veronica Costa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of FUBP1 inhibitors for treating hepatitis B virus infection
- Patent number 11,732,262
- Issue date Aug 22, 2023
- Souphalone Luangsay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides targeting ATXN3
- Patent number 11,542,501
- Issue date Jan 3, 2023
- HOFFMANN-LA ROCHE INC.
- Marianne Ravn Møller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for tre...
- Patent number 11,534,452
- Issue date Dec 27, 2022
- HOFFMANN-LA ROCHE INC.
- Hassan Javanbakht
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for tre...
- Patent number 11,484,546
- Issue date Nov 1, 2022
- Hoffman-La Roche Inc.
- Susanne Kammler
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for reduction of PD-L1 expression
- Patent number 11,466,081
- Issue date Oct 11, 2022
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for inducing paternal UBE3A expression
- Patent number 11,320,421
- Issue date May 3, 2022
- HOFFMANN-LA ROCHE INC.
- Veronica Costa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating ATXN2 expression
- Patent number 11,286,485
- Issue date Mar 29, 2022
- HOFFMANN-LA ROCHE INC.
- Peter Hagedorn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating ATXN2 expression
- Patent number 11,066,669
- Issue date Jul 20, 2021
- HOFFMANN-LA ROCHE INC.
- Peter Hagedorn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for tre...
- Patent number 10,953,034
- Issue date Mar 23, 2021
- HOFFMANN-LA ROCHE INC.
- Susanne Kammler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotides for reduction of PD-L1 expression
- Patent number 10,829,555
- Issue date Nov 10, 2020
- Hoffman-La Roche Inc.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotides for reduction of PD-L1 expression
- Patent number 10,745,480
- Issue date Aug 18, 2020
- Hoffmann-La Roche, Inc.
- Lykke Pedersen
- G01 - MEASURING TESTING
Information Patent Grant
Oligonucleotides for inducing paternal UBE3A expression
- Patent number 10,739,332
- Issue date Aug 11, 2020
- HOFFMANN-LA ROCHE INC.
- Veronica Costa
- G01 - MEASURING TESTING
Information Patent Grant
Oligonucleotides for inducing paternal UBE3A expression
- Patent number 10,718,753
- Issue date Jul 21, 2020
- Hoffman-La Roche Inc.
- Veronica Costa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotides for modulating HTRA1 expression
- Patent number 10,519,450
- Issue date Dec 31, 2019
- HOFFMANN-LA ROCHE INC.
- Roberto Iacone
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for inducing paternal UBE3A expression
- Patent number 10,494,633
- Issue date Dec 3, 2019
- Roche Innovation Center Copenhagen A/S
- Veronica Costa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Oligonucleotides for Modulating Apolipoprotein E4 Expression
- Publication number 20240294915
- Publication date Sep 5, 2024
- HOFFMANN-LA ROCHE INC.
- Helle NYMARK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING ADENOSINE KINASE
- Publication number 20240240188
- Publication date Jul 18, 2024
- NEUmiRNA Therapeutics Aps
- Markus Sakari Kauppinen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSION
- Publication number 20240182898
- Publication date Jun 6, 2024
- HOFFMANN-LA ROCHE INC.
- Erik FUNDER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGONUCLEOTIDE
- Publication number 20240167040
- Publication date May 23, 2024
- HOFFMANN-LA ROCHE INC.
- Gitte Friis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20240150758
- Publication date May 9, 2024
- HOFFMANN-LA ROCHE, INC.
- Souphalone LUANGSAY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION
- Publication number 20240085402
- Publication date Mar 14, 2024
- HOFFMANN-LA ROCHE INC.
- Veronica COSTA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20230331837
- Publication date Oct 19, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION
- Publication number 20230296587
- Publication date Sep 21, 2023
- HOFFMANN-LA ROCHE INC.
- Veronica COSTA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF A1CF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230257748
- Publication date Aug 17, 2023
- HOFFMANN-LA ROCHE INC.
- Dennis JUL HANSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TRE...
- Publication number 20230210887
- Publication date Jul 6, 2023
- HOFFMANN-LA ROCHE INC.
- Hassan JAVANBAKHT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Guanosine Analogues for Use in Therapeutics Polynucleotides
- Publication number 20230212572
- Publication date Jul 6, 2023
- Roche Innovation Center Copenhagen A/S
- Nanna Albaek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SBDS INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230193263
- Publication date Jun 22, 2023
- HOFFMANN-LA ROCHE INC.
- Souphalone Luangsay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SEPT9 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230183692
- Publication date Jun 15, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SARAF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230120063
- Publication date Apr 20, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF COPS3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230122751
- Publication date Apr 20, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SCAMP3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION
- Publication number 20230118138
- Publication date Apr 20, 2023
- HOFFMANN-LA ROCHE INC.
- Lykke Pedersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TRE...
- Publication number 20230113497
- Publication date Apr 13, 2023
- Hoffman-La Roche Inc.
- Susanne KAMMLER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Oligonucleotides Targeting ATXN3
- Publication number 20230060373
- Publication date Mar 2, 2023
- HOFFMANN-LA ROCHE INC.
- Heidi Rye Hudlebusch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense Oligonucleotides Targeting ATXN3
- Publication number 20230054720
- Publication date Feb 23, 2023
- HOFFMANN-LA ROCHE INC.
- Heidi Rye Hudlebusch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTEL1 EXPRESSION
- Publication number 20220251556
- Publication date Aug 11, 2022
- HOFFMANN-LA ROCHE INC.
- Erik FUNDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense Oligonucleotides Targeting ATXN3
- Publication number 20220177883
- Publication date Jun 9, 2022
- HOFFMANN-LA ROCHE INC.
- Heidi Rye Hudlebusch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION
- Publication number 20220146496
- Publication date May 12, 2022
- Roche Innovation Center Copenhagen A/S
- Veronica Costa
- G01 - MEASURING TESTING
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES FOR MODULATING HTRA1 EXPRESSION
- Publication number 20220042022
- Publication date Feb 10, 2022
- F. Hoffmann-La Roche AG
- Rubén Alvarez Sánchez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION
- Publication number 20220031730
- Publication date Feb 3, 2022
- HOFFMANN-LA ROCHE INC.
- Sabine SEWING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE OLIGONUCLEOTIDES TARGETING TIA1
- Publication number 20210261961
- Publication date Aug 26, 2021
- HOFFMANN-LA ROCHE INC.
- Veronica COSTA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING SCN9A EXPRESSION
- Publication number 20210238608
- Publication date Aug 5, 2021
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCED OLIGONUCLEOTIDES FOR INHIBITING SCN9A EXPRESSION
- Publication number 20210214727
- Publication date Jul 15, 2021
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING RTEL1 EXPRESSION
- Publication number 20210147850
- Publication date May 20, 2021
- HOFFMANN-LA ROCHE INC.
- Marco BERRERA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
- Publication number 20210147535
- Publication date May 20, 2021
- HOFFMANN-LA ROCHE INC.
- Lykke PEDERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGONUCLEOTIDES FOR MODULATING PIAS4 EXPRESSION
- Publication number 20210095274
- Publication date Apr 1, 2021
- Roche Innovation Center Copenhagen A/S
- Peter HAGEDORN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lykke Pedersen

Person

Patents Grantslast 30 patents

Oligonucleotides for inducing paternal UBE3A expression

Oligonucleotides for modulating SCN9A expression

Enhanced oligonucleotides for inhibiting RTEL1 expression

Oligonucleotides for inducing paternal UBE3A expression

Use of FUBP1 inhibitors for treating hepatitis B virus infection

Antisense oligonucleotides targeting ATXN3

Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for tre...

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for tre...

Oligonucleotides for reduction of PD-L1 expression

Oligonucleotides for inducing paternal UBE3A expression

Oligonucleotides for modulating ATXN2 expression

Oligonucleotides for modulating ATXN2 expression

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for tre...

Oligonucleotides for reduction of PD-L1 expression

Oligonucleotides for reduction of PD-L1 expression

Oligonucleotides for inducing paternal UBE3A expression

Oligonucleotides for inducing paternal UBE3A expression

Antisense oligonucleotides for modulating HTRA1 expression

Oligonucleotides for inducing paternal UBE3A expression

Patents Applicationslast 30 patents

Oligonucleotides for Modulating Apolipoprotein E4 Expression

ANTISENSE OLIGONUCLEOTIDES TARGETING ADENOSINE KINASE

ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSION

ANTISENSE OLIGONUCLEOTIDE

USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

USE OF A1CF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TRE...

Guanosine Analogues for Use in Therapeutics Polynucleotides

USE OF SBDS INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SEPT9 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SARAF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF COPS3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

USE OF SCAMP3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

NUCLEIC ACID MOLECULE FOR REDUCTION OF PAPD5 AND PAPD7 mRNA FOR TRE...

Antisense Oligonucleotides Targeting ATXN3

Antisense Oligonucleotides Targeting ATXN3

ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTEL1 EXPRESSION

Antisense Oligonucleotides Targeting ATXN3

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

ANTISENSE OLIGONUCLEOTIDES FOR MODULATING HTRA1 EXPRESSION

ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION

ANTISENSE OLIGONUCLEOTIDES TARGETING TIA1

OLIGONUCLEOTIDES FOR MODULATING SCN9A EXPRESSION

ENHANCED OLIGONUCLEOTIDES FOR INHIBITING SCN9A EXPRESSION

OLIGONUCLEOTIDES FOR MODULATING RTEL1 EXPRESSION

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

OLIGONUCLEOTIDES FOR MODULATING PIAS4 EXPRESSION